Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biochemistry ; 36(10): 3018-26, 1997 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-9062133

RESUMO

We incorporated a phosphonate irreversible inhibitor of neutrophil elastase into a randomized DNA library and, using the SELEX process, iteratively selected these assemblies for the most potent elastase inhibitors. The inhibitors were selected against purified elastase and against secreted elastase in the presence of activated neutrophils. Very active aptamer inhibitors were obtained by both methods, with second-order rate constants for inactivation of human neutrophil elastase ranging (1-3) x 10(8) M(-1) min(-1). These rates exceed those of any reported irreversible inhibitor of elastase and exceed the previous best phosphonate inhibitors by 80-fold. The selected inhibitors are also significantly more potent than alpha-1 proteinase inhibitor in blocking degradation of elastin by activated neutrophils. In contrast to a previous experiment [Smith et al. (1995) Chem. Biol. 2, 741-750], a single-enantiomer form of the valyl phosphonate was used rather than a racemic mixture. Our analysis shows that this use of a chirally resolved valyl phosphonate results in selection of much more potent inhibitors and that these inhibitors specifically potentiate a single enantiomeric form of the phosphonate.


Assuntos
Elastase de Leucócito/antagonistas & inibidores , Neutrófilos/enzimologia , Oligodesoxirribonucleotídeos/farmacologia , Organofosfonatos/farmacologia , Inibidores de Serina Proteinase/síntese química , Inibidores de Serina Proteinase/farmacologia , Catepsina G , Catepsinas/antagonistas & inibidores , Fluoresceína , Fluoresceínas/metabolismo , Fluorescência , Biblioteca Gênica , Humanos , Cinética , Modelos Químicos , Conformação Molecular , Neutrófilos/efeitos dos fármacos , Conformação de Ácido Nucleico , Oligodesoxirribonucleotídeos/química , Organofosfonatos/química , Sais/farmacologia , Análise de Sequência , Serina Endopeptidases , Especificidade por Substrato , Valina
2.
Chem Biol ; 2(11): 741-50, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9383481

RESUMO

INTRODUCTION: We describe a new approach to drug discovery which joins the technologies of medicinal and combinatorial chemistry, allowing selection of the most active variant of a lead compound from a large (> 10(12)) pool. A small-molecule covalent inhibitor of elastase was coupled to a randomized pool of RNA, and this assembly was iteratively selected for oligonucleotide sequences that promote the covalent reaction of the inhibitor with the human neutrophil elastase (hNE) active site. RESULTS: Incorporation of the covalent inhibitor into the randomized pool increases the second-order rate of inactivation of hNE by approximately 15-fold; sequences selected from this pool show an additional approximately 20-fold increase in activity. The relative rate of cross-reaction with another serine protease, cathepsin G, was reduced > 100-fold. Low doses of the inhibitor were found to prevent lung damage inflicted by human neutrophils in an isolated rat lung model of acute respiratory distress syndrome (ARDS). CONCLUSIONS: This result supports the hypothesis that neutrophil elastase is a significant effector of inflammatory disease. More generally, our findings demonstrate that blending small molecules into combinatorial libraries is a feasible method of drug discovery.


Assuntos
Elastase de Leucócito/antagonistas & inibidores , Neutrófilos/enzimologia , Oligonucleotídeos/química , Oligonucleotídeos/farmacologia , RNA/química , RNA/farmacologia , Inibidores de Serina Proteinase/síntese química , Animais , Sequência de Bases , Catepsina G , Catepsinas/antagonistas & inibidores , Catepsinas/química , Fenômenos Químicos , Físico-Química , Reações Cruzadas , Humanos , Dados de Sequência Molecular , Tamanho do Órgão , Reação em Cadeia da Polimerase , Ratos , Síndrome do Desconforto Respiratório/patologia , Síndrome do Desconforto Respiratório/prevenção & controle , Serina Endopeptidases , Inibidores de Serina Proteinase/farmacologia , Inibidores de Serina Proteinase/uso terapêutico , Especificidade por Substrato
4.
J Assoc Off Anal Chem ; 71(4): 725-8, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-3138227

RESUMO

beta-Cyclodextrin enhances the fluorescence of aflatoxins B1 and G1 in aqueous systems. This effect was utilized in developing a unique reverse-phase liquid chromatographic (LC) method for determination of aflatoxins B1, B2, G1, and G2 (B1 detection limit 1 ppb), without preparing derivatives of B1 and G1. The aflatoxins are dissolved in methanol or the mobile phase for injection onto the LC system. Using a mobile phase of methanol-beta-cyclodextrin (1 + 1), the aflatoxins are resolved on a C18 column. Fluorescence of the aflatoxins is enhanced by post-column introduction of an aqueous concentrated beta-cyclodextrin solution. All 4 aflatoxins elute within 10 min in the order G2, G1, B2, B1. Fluorescence responses for B1 and G1 standards were linear over the concentration range 0.5-10 ng, yielding correlation coefficients (r) of 0.9989 and 1.000, respectively. The average peak response ratio for G1:B1 for the mobile phase-enhancement solution described was 0.765 with a coefficient of variation (CV) of 0.98%. CVs were 6.2, 9.0, and 7.5% for multiple assays of aflatoxin B1 in 3 samples of naturally contaminated corn. For samples of corn spiked to a total B1 content of 8.3 ng/g, average B1 recovery was 90% (CV 11.7%).


Assuntos
Aflatoxinas/análise , Ciclodextrinas , Dextrinas , Contaminação de Alimentos/análise , Amido , Zea mays/análise , beta-Ciclodextrinas , Aflatoxina B1 , Cromatografia Líquida , Modelos Moleculares , Conformação Molecular , Solventes
5.
J Assoc Off Anal Chem ; 71(1): 41-3, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-3360704

RESUMO

Data were gathered, during a study on the development of an automated system for the extraction, cleanup, and quantitation of mycotoxins in corn, to determine if it was scientifically sound to reduce the analytical sample size. Five, 10, and 25 g test portions were analyzed and statistically compared with 50 g test portions of the same composites for aflatoxin concentration variance. Statistical tests used to determine whether the 10 and 50 g sample sizes differed significantly showed a satisfactory observed variance ratio (Fobs) of 2.03 for computations of pooled standard deviations; paired t-test values of 0.952, 1.43, and 0.224 were computed for each of the 3 study samples. The results meet acceptable limits, since each sample's t-test result is less than the published value of the /t/, which is 1.6909 for the test conditions. The null hypothesis is retained since the sample sizes do not give significantly different values for the mean analyte concentration. The percent coefficients of variation (CVs) for all samples tested were within the expected range. In addition, the variance due to sample mixing was evaluated using radioisotope-labeled materials, yielding an acceptable CV of 22.2%. The variance due to the assay procedure was also evaluated and showed an aflatoxin B, recovery of 78.9% and a CV of 11.4%. Results support the original premise that a sufficiently ground and blended sample would produce an analyte variance for a 10 g sample that was statistically comparable with that for a 50 g sample.


Assuntos
Contaminação de Alimentos/análise , Micotoxinas/análise , Zea mays/análise , Aflatoxinas/análise , Cromatografia em Camada Fina
6.
J Assoc Off Anal Chem ; 70(5): 842-4, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3680122

RESUMO

A collaborative study of a method for the determination of sterigmatocystin in cheese was conducted by 10 laboratories. The study included control samples and samples spiked at levels of 5, 10, and 25 ppb, in coded blind pairs. Recoveries were 60.0, 90.7, and 59.3%, outliers excluded, for the respective levels. The mean reproducibilities, outliers excluded, were 81.97, 17.13, and 52.77%, respectively. Mean repeatabilities, outliers excluded, were 77.66, 17.13, and 46.40%, respectively. Results of this collaborative study indicate that the method, modified as described in this report, is applicable to the determination of sterigmatocystin in cheese at low levels (5-50 ppb) for the purpose of surveys. With regard to the difficulty with thin-layer chromatography in this study, it is recommended that a more satisfactory determinative step be developed. Recommendation for official first action status is deferred.


Assuntos
Queijo/análise , Esterigmatocistina/análise , Xantenos/análise , Cromatografia em Camada Fina , Microbiologia de Alimentos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA